Evidence map›Paper›PMID 42682849›Full record

ArticleFrontiers in cellular and infection microbiology2026

Pulmonarom

Sandra Georgina Solano-Gálvez, Juan A Hernández-Aceves, Alberto García Lozano, Arturo A Wilkins-Rodríguez, Diego Alexander Rojas Ortega, Antonio Ibarra, Exsal Manuel Albores Méndez, Edda Sciutto, Laila Gutiérrez-Kobeh, Horacio Merchant Larios and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sandra Georgina Solano-Gálvez *Unidad de Investigación Universidad Nacional Autónoma de México - Instituto Nacional de Cardiología (UNAM-INC), División de Investigación, Facultad de Medicina, Ciudad de México, Mexico.
Juan A Hernández-Aceves *Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Alberto García LozanoLaboratorio de Inmunobiología, Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Arturo A Wilkins-RodríguezUnidad de Investigación Universidad Nacional Autónoma de México - Instituto Nacional de Cardiología (UNAM-INC), División de Investigación, Facultad de Medicina, Ciudad de México, Mexico.
Diego Alexander Rojas OrtegaCentro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud Universidad Anáhuac México Norte, Huixquilucan, Mexico.
Antonio IbarraCentro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud Universidad Anáhuac México Norte, Huixquilucan, Mexico.
Exsal Manuel Albores MéndezEscuela Militar de Graduados en Sanidad Universidad del Ejército y Fuerza Aérea Secretaría de la Defensa Nacional México, Ciudad de México, Mexico.
Edda SciuttoDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Laila Gutiérrez-KobehUnidad de Investigación Universidad Nacional Autónoma de México - Instituto Nacional de Cardiología (UNAM-INC), División de Investigación, Facultad de Medicina, Ciudad de México, Mexico.
Horacio Merchant LariosLaboratorio de Biología Celular y Fisiología Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Carlos Cabello-GutiérrezDepartamento de Investigación en Virología y Micología, Instituto Nacional de Enfermedades Respiratorias (INER), Ciudad de México, Mexico.
Gladis FragosoDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Rosalino Vázquez-LópezCentro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud Universidad Anáhuac México Norte, Huixquilucan, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bacterial lysates have been associated with improved host defense against respiratory infections; however, their mechanisms of action remain incompletely understood. Based on our previous Materials and methods: Human monocytes obtained from buffy coats were differentiated into moDCs. Lyophilized Pulmonarom Results: Under both pre-exposure and post-infection treatment conditions, Pulmonarom Conclusions: Pulmonarom

Indexed as

Dendritic CellsImmunologic FactorsInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInterferonsToll-Like ReceptorsAnimalsBacterial LysatesCells, CulturedCytokinesDogsHumansMonocytesToll-Like Receptor AgonistsBacterial LysatesCytokinesImmunologic FactorsInterferonsToll-Like Receptor AgonistsToll-Like Receptorsantiviraldendritic cellsimmunomodulatorsinfluenza virus (H1N1 and H3N2)interferonpostbioticPulmonarom®TLR

Identifiers

PMID42682849
PMCPMC13531035

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.